Working Opportunity Fund - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $97,824.62 +3.92%
Ethereum $3,468.85 +2.44%
BNB $697.80 +1.36%
Optimism $1.95 +2.78%
Arbitrum $0.81 +2.48%
Solana $199.83 +6.29%
Polygon $0.52 +5.83%
Cosmos $7.00 +2.91%
Avalanche $41.39 +8.26%

Bitcoin $97,824.62 +3.92%
Ethereum $3,468.85 +2.44%
BNB $697.80 +1.36%
Optimism $1.95 +2.78%
Arbitrum $0.81 +2.48%
Solana $199.83 +6.29%
Polygon $0.52 +5.83%
Cosmos $7.00 +2.91%
Avalanche $41.39 +8.26%

Working Opportunity Fund

investment firm

Summary
Investments
Exits

About

Working Opportunity Fund is a venture capital fund specialized in early-stage investments.

Vancouver,British Columbia,Canada
https://www.penderfund.com/funds/working-opportunity-fund/

Highlights

Lead Investments

Details

Founded date: Jan 1, 2003
Operating Status: Active
Also Known As: PenderFund Capital Management,WOF
Investor Type: Venture Capital

Management of the Working Opportunity Fund transferred to PenderFund Capital on March 1, 2019

Investments

Number of Investments

Number of Lead Investments

7

1

Working Opportunity Fund has made 7 investments. Their most recent investment was on Sep 29, 2011, when MSI Methylation Sciences raised €13.50M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 29, 2011 MSI Methylation Sciences	Series A	€13.50M	Biotechnology	—
Apr 7, 2009 Teradici	Series C	$17M	Enterprise Software	—
Feb 14, 2007 Teradici	Series B	$18M	Enterprise Software	—
Feb 3, 2005 GenoLogics	Series A	$5M	Biotechnology	—
Oct 29, 2003 OncoGenex	Post-IPO Equity	$11.50M	Biotechnology	Yes

Show More

Exits

Working Opportunity Fund has had 4 exits. Working Opportunity Fund most notable exits include AppNeta , Teradici

Date	Company Name	Exit Type	Industry
Dec 7, 2021	AppNeta	M&A	Cloud Computing	Detail
Jul 27, 2021	Teradici	M&A	Enterprise Software	Detail
Aug 4, 2015	GenoLogics	M&A	Biotechnology	Detail
Oct 20, 1995	OncoGenex	M&A	Biotechnology	Detail